Voxelotor is prescribed for:
- Sickle cell disease in patients 4 years and older
- Reducing hemolysis
- Hematology hemoglobin disorders
First drug to directly prevent hemoglobin polymerization.
Back to Medication Guide
Voxelotor
Generic Name: Voxelotor
Brand Names: Oxbryta
Voxelotor is a sickle cell disease treatment that increases hemoglobin's oxygen affinity to prevent sickling.
Hematology
What It's Used For
Side Effects
Common side effects:
- Headache
- Diarrhea
- Abdominal pain
- Nausea
- Fatigue
- Rash
Serious side effects are rare but include hypersensitivity reactions.
Additional Information
What is Voxelotor?
Voxelotor is a hemoglobin S polymerization inhibitor that prevents red blood cell sickling in sickle cell disease.
Novel Mechanism
Works by increasing hemoglobin's affinity for oxygen, keeping hemoglobin in its oxygenated (non-sickling) form.
Hemoglobin Improvement
Increases hemoglobin levels and reduces markers of hemolysis.
Learn more at MedlinePlus.
Medical Disclaimer: This information is for educational purposes only and should not be considered medical advice. Always consult with your healthcare provider before starting, stopping, or changing any medication. Your doctor can provide personalized recommendations based on your specific health condition and medical history.
Loading questions...
Ask Dr. Zimmer
Have questions about Voxelotor? Get expert answers from Dr. Zimmer.
Privacy: Your questions are posted anonymously for your health privacy. Your name and email are only used for admin purposes.
Questions are reviewed before posting. You'll see your question and Dr. Zimmer's answer below once approved.